You have 9 free searches left this month | for more free features.

14-211

Showing 1 - 25 of 8,766

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Malignant Tumor Trial in Seattle (biological, drug, radiation, procedure)

Recruiting
  • Non-Malignant Neoplasm
  • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
  • +7 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 29, 2022

Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac

Active, not recruiting
  • Vascular Death
  • +3 more
    • Los Angeles, California
    • +23 more
    Jan 11, 2022

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)

    Not yet recruiting
    • Cutaneous Tumor
    • Malignant Solid Tumor
    • JCXH-211 Injection
    • (no location specified)
    Feb 13, 2023

    Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

    Completed
    • Human Papillomavirus (HPV)-Related Malignancies
    • Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
    • Basking Ridge, New Jersey
    • +5 more
    Dec 14, 2022

    GI Adenocarcinoma Trial in Germany, Netherlands (AMG 211)

    Terminated
    • GI Adenocarcinoma
    • AMG 211
    • Hamburg, Germany
    • +4 more
    Feb 23, 2021

    Cutaneous Tumor, Malignant Solid Tumor Trial in Houston (JCXH-211)

    Not yet recruiting
    • Cutaneous Tumor
    • Malignant Solid Tumor
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Sep 9, 2022

    Pulmonary Hypertension, Interstitial Lung Disease Trial (Treprostinil Palmitil Inhalation Powder, Placebo)

    Not yet recruiting
    • Pulmonary Hypertension
    • Interstitial Lung Disease
    • Treprostinil Palmitil Inhalation Powder
    • Placebo
    • (no location specified)
    Jan 23, 2023

    Crohn's Disease Trial (Vedolizumab IV, Placebo)

    Not yet recruiting
    • Crohn's Disease
    • Vedolizumab IV
    • Placebo
    • (no location specified)
    Apr 20, 2023

    Metastatic Triple Negative Breast Cancer Trial in Worldwide (Olaparib Continuous (28-Day cycle) 300 mg BD., Ceralasertib 160 mg

    Active, not recruiting
    • Metastatic Triple Negative Breast Cancer
    • Olaparib Continuous (28-Day cycle) 300 mg BD.
    • +2 more
    • Birmingham, Alabama
    • +140 more
    Nov 17, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +11 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 29, 2022

    Cataract Trial in United States (Clobetasol propionate, Vehicle)

    Completed
    • Cataract
    • Chandler, Arizona
    • +21 more
    Nov 30, 2022

    Coronavirus, Covid19, SARS-CoV-2 Trial in Brussels, Liège (CVnCoV Vaccine)

    Terminated
    • Coronavirus
    • +3 more
    • CVnCoV Vaccine
    • Brussels, Belgium
    • +3 more
    Apr 20, 2022

    Social and Genetic Factors on Outcomes in Adolescent and Young

    Not yet recruiting
    • Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    Aug 18, 2023

    ß-thalassemia Trial (BD211)

    Not yet recruiting
    • β-thalassemia
    • BD211
    • (no location specified)
    Mar 15, 2023

    ß-thalassemia Trial in Shanghai (BD211)

    Not yet recruiting
    • β-thalassemia
    • BD211
    • Shanghai, China
      Shanghai Ruijin Hospital
    Mar 16, 2023

    Sleep Disorder, Anxiety, Quality of Life Trial in Urbino (Melissa phytosome, Placebo)

    Not yet recruiting
    • Sleep Disorder
    • +2 more
    • Melissa phytosome
    • Placebo
    • Urbino, Italy
      University of Urbino Carlo Bo
    Jul 10, 2023

    Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

    Enrolling by invitation
    • Lymphoma, B-Cell
    • +4 more
    • Burbank, California
    • +90 more
    Mar 31, 2022

    Overweight, Obesity Trial in Worldwide (Gelesis100, )

    Completed
    • Overweight
    • Obesity
    • Gelesis100
    • placebo
    • Anaheim, California
    • +35 more
    Aug 8, 2022

    Helicobacter Pylori Infection Trial in China (Amoxicillin, Clarithromycin, Tetracycline)

    Recruiting
    • Helicobacter Pylori Infection
    • Nanjing, Jiangsu, China
    • +5 more
    Jun 18, 2022

    COVID-19 Trial in United States (Ad26.COV2.S, BNT162b2, mRNA-1273)

    Recruiting
    • COVID-19
    • Ad26.COV2.S
    • +4 more
    • Atlanta, Georgia
    • +11 more
    Aug 11, 2022

    SARS-CoV-2 Trial in United States (mRNA-1273.211, mRNA-1273, mRNA-1273.617.2)

    Active, not recruiting
    • SARS-CoV-2
    • mRNA-1273.211
    • +6 more
    • Sacramento, California
    • +22 more
    Nov 16, 2022

    Fracture, Radius Fracture Distal Trial (Wrist arthroscopy)

    Not yet recruiting
    • Fracture
    • Radius Fracture Distal
    • Wrist arthroscopy
    • (no location specified)
    Oct 16, 2022

    Cystic Fibrosis Trial in France, Poland, Ukraine (tobramycin)

    Completed
    • Cystic Fibrosis
    • Caen, France
    • +19 more
    Jul 30, 2020

    Helicobacter Pylori Infection Trial in Coyhaique, Santiago, Temuco (Lansoprazole, Amoxicillin, Clarithromycin)

    Recruiting
    • Helicobacter Pylori Infection
    • Coyhaique, Chile
    • +2 more
    Jun 23, 2023